← 產業報告目錄

Smart Syringes Market Size, Share & Trends Analysis Report By Product (With Needle (Fixed, Exchangeable), Without Needle Bioalcohols), By Volume (Below 1000 μL, Above 1000 μL), By Application (Medical (Drug Delivery, Blood Sample Collection, Vaccination), Non -Medical use), By Region, And by Segment Forecasts, 2024-2031

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-06頁數 180報告編號 INSIGHTACE-f07cc5192b

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

In 2023, the Smart Syringes Market worldwide was assessed at USD 67.29 Mn. Analysts project it will advance to USD 145.62 Mn by 2031, at a CAGR of 10.21% spanning 2024 to 2031. The Smart Syringes sector involves The increased cases of chronic diseases, including diabetes, cancer, and autoimmune disorders, drive the demand for smart syringes, which are used to give medications and immunizations. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics. Market momentum is driven by rising need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Smart Syringes Market Snapshot Chapter 4. Global Smart Syringes Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact Analysis Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis 5.1. By Type & Market Share, 2019-2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type: 5.2.1. With Needle 5.2.1.1 Fixed 5.2.1.2 Exchangeable 5.2.2. Without Needle Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis 6.1. By Type & Market Share, 2019-2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application: 6.2.1. Medical Use 6.2.1.1. Drug Delivery 6.2.1.2. Blood Sample Collection 6.2.1.3. Vaccination 6.2.2. Non-medical Use Chapter 7. Market Segmentation 3: By Volume Estimates & Trend Analysis 7.1. By Type & Market Share, 2019-2031 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Volume: 7.2.1. Below 1000 µL 7.2.2. Above 1000 µL Chapter 8. Smart Syringes Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031 8.1.2. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031 8.1.3. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031 8.1.4. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By country, 2023-2031 8.1.4.1. U.S. 8.1.5. Canada 8.2. Europe 8.2.1. Europe Smart Syringes Market revenue (US$ Million) By Type, 2023-2031 8.2.2. Europe Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031 8.2.3. Europe Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031 8.2.4. Europe Smart Syringes Market revenue (US$ Million) By country, 2023-2031 8.2.4.1. Germany 8.2.4.2. Poland 8.2.4.3. France 8.2.4.4. Italy 8.2.4.5. Spain 8.2.4.6. UK 8.2.4.7. Rest of Europe 8.3. Asia Pacific 8.3.1. Asia Pacific Smart Syringes Market revenue (US$ Million) By Type, 2023-2031 8.3.2. Asia Pacific Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031 8.3.3. Asia Pacific Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031 8.3.4. Asia Pacific Smart Syringes Market revenue (US$ Million) By country, 2023-2031 8.3.4.1. China 8.3.4.2. India 8.3.4.3. Japan 8.3.4.4. Australia 8.3.4.5. Rest of Asia Pacific 8.4. Latin America 8.4.1. Latin America Smart Syringes Market revenue (US$ Million) By Type, 2023-2031 8.4.2. Latin America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031 8.4.3. Latin America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031 8.4.4. Latin America Smart Syringes Market revenue (US$ Million) By country, (US$ Million) 2023-2031 8.4.4.1. Brazil 8.4.4.2. Rest of Latin America 8.5. Middle East & Africa 8.5.1. Middle East & Africa Smart Syringes Market revenue (US$ Million) By Type, (US$ Million) 8.5.2. Middle East & Africa Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031 8.5.3. Middle East & Africa Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031 8.5.4. Middle East & Africa Smart Syringes Market revenue (US$ Million) By country, (US$ Million) 2023-2031 8.5.4.1. South Africa 8.5.4.2. GCC Countries 8.5.4.3. Rest of MEA Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Agilent Technologies, Inc. 9.2.2. Schott AG 9.2.3. Shimadzu Corporation 9.2.4. Thermo Fisher Scientific Inc. 9.2.5. Trajan LEAP PAL Parts + Consumables 9.2.6. Clayens-np 9.2.7. Becton, Dickinson and Co. 9.2.8. B. Braun Melungeon AG 9.2.9. Terumo Medical Corporation 9.2.10. Baxter International, Inc 9.2.11. Retractable Technologies, Inc 9.2.12. Smith's Group Plc 9.2.13. Merck & Company Inc. 9.2.14. Medtronic Plc (Covidien) 9.2.15. Unilife Corporation 9.2.16. Revolutions Medical Corporation 9.2.17. AdvaCare Pharma 9.2.18. Cardinal Health 9.2.19. Parker Hannifin Corp. 9.2.20. Numedico Technologies Pty Ltd 9.2.21. Thomas Scientific (U.S), 9.2.22. McKesson Medical-Surgical Inc. (U.S)

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們